A strategy to boost the immune response to vaccination in patients with seropositive rheumatoid arthritis.
Reference1. Colmegna I, Useche M, Rodriguez K, et al. Efficacy of High-Dose Versus Standard-Dose Influenza Vaccine in Seropositive Rheumatoid Arthritis Patients [Abstract 837]. Arthritis Rheumatol. 2018;70(suppl 10). Accessed October 31, 2018.This information is brought to you by Rheumatology Network and is not sponsored by, nor a part of, the American College of Rheumatology.